
Remicade Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts
Description
Remicade Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on remicade market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for remicade ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The remicade market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Disease Indication: Crohn’s disease; Rheumatoid arthritis; Ankylosing spondylitis; Psoriatic arthritis; Ulcerative Colitis; Plaque psoriasis
2) By Route Of Administration: Subcutaneous; Intravenous; Parenteral
3) By End Use: Hospitals; Clinics; Ambulatory Care; Home Care
Companies Mentioned: Janssen Biotech Inc.
Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on remicade market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for remicade ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The remicade market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Disease Indication: Crohn’s disease; Rheumatoid arthritis; Ankylosing spondylitis; Psoriatic arthritis; Ulcerative Colitis; Plaque psoriasis
2) By Route Of Administration: Subcutaneous; Intravenous; Parenteral
3) By End Use: Hospitals; Clinics; Ambulatory Care; Home Care
Companies Mentioned: Janssen Biotech Inc.
Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Remicade Market Characteristics
- 3. Remicade Market Biologic Drug Characteristics
- 3.1. Molecule Type
- 3.2. Route Of Administration (ROA)
- 3.3. Mechanism Of Action (MOA)
- 3.4. Safety And Efficacy
- 4. Remicade Market Trends And Strategies
- 5. Remicade Market -Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
- 6. Global Remicade Growth Analysis And Strategic Analysis Framework
- 6.1. Global Remicade PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 6.2. Analysis Of End Use Industries
- 6.3. Global Remicade Market Growth Rate Analysis
- 6.4. Global Remicade Historic Market Size and Growth, 2019 - 2024, Value ($ Million)
- 6.5. Global Remicade Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)
- 6.6. Global Remicade Total Addressable Market (TAM)
- 7. Global Remicade Pricing Analysis & Forecasts
- 8. Remicade Market Segmentation
- 8.1. Global Remicade Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- Crohn’s disease
- Rheumatoid arthritis
- Ankylosing spondylitis
- Psoriatic arthritis
- Ulcerative Colitis
- Plaque psoriasis
- 8.2. Global Remicade Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- Subcutaneous
- Intravenous
- Parenteral
- 8.3. Global Remicade Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- Hospitals
- Clinics
- Ambulatory Care
- Home Care
- 9. Global Remicade Epidemiology Of Clinical Indications
- 9.1. Drug Side Effects
- 9.2. Incidence And Prevalence of Clinical Indications
- 10. Remicade Market Regional And Country Analysis
- 10.1. Global Remicade Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 10.2. Global Remicade Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 11. Asia-Pacific Remicade Market
- 11.1. Asia-Pacific Remicade Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 11.2. Asia-Pacific Remicade Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 11.3. Asia-Pacific Remicade Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 11.4. Asia-Pacific Remicade Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 12. China Remicade Market
- 12.1. China Remicade Market Overview
- 12.2. China Remicade Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
- 12.3. China Remicade Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
- 12.4. China Remicade Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
- 13. India Remicade Market
- 13.1. India Remicade Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 13.2. India Remicade Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 13.3. India Remicade Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 14. Japan Remicade Market
- 14.1. Japan Remicade Market Overview
- 14.2. Japan Remicade Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 14.3. Japan Remicade Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 14.4. Japan Remicade Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 15. Australia Remicade Market
- 15.1. Australia Remicade Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 15.2. Australia Remicade Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 15.3. Australia Remicade Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 16. South Korea Remicade Market
- 16.1. South Korea Remicade Market Overview
- 16.2. South Korea Remicade Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 16.3. South Korea Remicade Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 16.4. South Korea Remicade Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 17. Western Europe Remicade Market
- 17.1. Western Europe Remicade Market Overview
- 17.2. Western Europe Remicade Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 17.3. Western Europe Remicade Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 17.4. Western Europe Remicade Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 18. UK Remicade Market
- 18.1. UK Remicade Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 18.2. UK Remicade Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 18.3. UK Remicade Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 19. Germany Remicade Market
- 19.1. Germany Remicade Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 19.2. Germany Remicade Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 19.3. Germany Remicade Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 20. France Remicade Market
- 20.1. France Remicade Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 20.2. France Remicade Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 20.3. France Remicade Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 21. Eastern Europe Remicade Market
- 21.1. Eastern Europe Remicade Market Overview
- 21.2. Eastern Europe Remicade Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 21.3. Eastern Europe Remicade Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 21.4. Eastern Europe Remicade Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 22. North America Remicade Market
- 22.1. North America Remicade Market Overview
- 22.2. North America Remicade Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 22.3. North America Remicade Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 22.4. North America Remicade Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 23. USA Remicade Market
- 23.1. USA Remicade Market Overview
- 23.2. USA Remicade Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 23.3. USA Remicade Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 23.4. USA Remicade Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 24. Canada Remicade Market
- 24.1. Canada Remicade Market Overview
- 24.2. Canada Remicade Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 24.3. Canada Remicade Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 24.4. Canada Remicade Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 25. South America Remicade Market
- 25.1. South America Remicade Market Overview
- 25.2. South America Remicade Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 25.3. South America Remicade Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 25.4. South America Remicade Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 26. Middle East Remicade Market
- 26.1. Middle East Remicade Market Overview
- 26.2. Middle East Remicade Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 26.3. Middle East Remicade Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 26.4. Middle East Remicade Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 27. Africa Remicade Market
- 27.1. Africa Remicade Market Overview
- 27.2. Africa Remicade Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 27.3. Africa Remicade Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 27.4. Africa Remicade Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- 28. Remicade Market Competitive Landscape And Company Profiles
- 28.1. Remicade Market Competitive Landscape
- 28.2. Remicade Market Company Profiles
- 28.2.1. Janssen Biotech Inc. Overview, Products and Services, Strategy and Financial Analysis
- 29. Global Remicade Market Pipeline Analysis
- 29.1. High Level Clinic Trail Information
- 30. Global Remicade Market Competitive Benchmarking And Dashboard
- 31. Key Mergers And Acquisitions In The Remicade Market
- 32. Recent Developments In The Remicade Market
- 33. Remicade Market High Potential Countries, Segments and Strategies
- 33.1 Remicade Market In 2029 - Countries Offering Most New Opportunities
- 33.2 Remicade Market In 2029 - Segments Offering Most New Opportunities
- 33.3 Remicade Market In 2029 - Growth Strategies
- 33.3.1 Market Trend Based Strategies
- 33.3.2 Competitor Strategies
- 34. Appendix
- 34.1. Abbreviations
- 34.2. Currencies
- 34.3. Historic And Forecast Inflation Rates
- 34.4. Research Inquiries
- 34.5. The Business Research Company
- 34.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.